CCL13 and gastric cancer: Here, we demonstrate the clinical significance of a distinct immunosuppressive macrophage signature, M2TS (MRC1, MS4A4A, CD36, CCL13, CCL18, CCL23, SLC38A6, FGL2, FN1, MAF) in GC patients.